JPRN-UMIN000030850已完成未知
An observational study to discover novel biomarkers for nivolumab in patients with advanced gastric cancer (DELIVER trial): JACCRO GC-08 - An observational/translational study for nivolumab in gastric cancer (DELIVER trial): JACCRO GC-08
Japan Clinical Cancer Research Organization (JACCRO)0 个研究点目标入组 501 人开始时间: 2018年1月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 501
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients previously treated with nivolumab (2) HBs antigen-positive or HCV antibody-positive (3) Patients who are regarded as inadequate for study enrollment by investigators.
研究者
相似试验
招募中
不适用
An observational study to determine biomarkers for prognosis of lung lesions in patients with polymyositis/dermatomyositis complicated by interstitial lung diseasePolymyositis/dermatomyositis complicated with interstitial lung disease (PM/DM-ILD)JPRN-UMIN000046198agasaki University125
已完成
不适用
Observational study on the detection of biomarkers of diseases of the respiratory system by means of ion mobility spectrometry.J98.8U07.1Other specified respiratory disordersCOVID-19, virus identifiedDRKS00025842Immanuel Klinikum Bernau Herzzentrum Brandenburg Hochschulklinikum der Medizinischen Hochschule Brandenburg137
暂停
不适用
A study exploring new biomarkers by measuring the rest-activity rhythms of patients with schizophrenia and mood disordersSchizophrenia and mood disordersJPRN-UMIN000045175Fujita Health University90
尚未招募
不适用
This is an observational trial planned to study the levels of biomarkers bio-ADM and penKid for shock/multiorgan failure in patients with sepsis (also known as blood poisoning).CTRI/2023/01/048819Rivaara Labs Pvt. Ltd.
已完成
不适用
Biomarker study; study to identify biomarkers for protein intake, a randomized, fully controlled feeding studyGeen aandoeningenUitscheiding van biomerkers na het eten van eiwit in het gezond menselijk lichaamBiomarkers of protein intakeNL-OMON36525Wageningen Universiteit25
